Fields »
ABOUT
HELP
BLOG

551 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
SCN3ASodium channel, voltage gated, type III alpha subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN3BSodium channel, voltage gated, type III beta subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Nuclear membrane
Cytokinetic bridge		Tissue enriched
SCN4ASodium channel, voltage gated, type IV alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Microtubule organizing center		Group enriched
SCN4BSodium channel, voltage gated, type IV beta subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SCN9ASodium channel, voltage gated, type IX alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Focal adhesion sites		Tissue enhanced
SCNN1ASodium channel, non voltage gated 1 alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
SCNN1BSodium channel, non voltage gated 1 beta subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
SCNN1DSodium channel, non voltage gated 1 delta subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membrane
Actin filaments		Tissue enhanced
SCNN1GSodium channel, non voltage gated 1 gamma subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Nucleoli
Plasma membrane		Tissue enhanced
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
SDHDSuccinate dehydrogenase complex, subunit D, integral membrane proteinCancer-related genes
Citric acid cycle related proteins
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enriched
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
SHMT1Serine hydroxymethyltransferase 1 (soluble)Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol		Expressed in all
SISucrase-isomaltase (alpha-glucosidase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
SIGMAR1Sigma non-opioid intracellular receptor 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
SIRT5Sirtuin 5FDA approved drug targets
Predicted intracellular proteins
MitochondriaExpressed in all
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A2Solute carrier family 12 (sodium/potassium/chloride transporter), member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Vesicles
Plasma membrane		Expressed in all
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A4Solute carrier family 12 (potassium/chloride transporter), member 4FDA approved drug targets
Predicted membrane proteins
Transporters
EndosomesExpressed in all
SLC12A5Solute carrier family 12 (potassium/chloride transporter), member 5FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC18A1Solute carrier family 18 (vesicular monoamine transporter), member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A11Solute carrier family 22 (organic anion/urate transporter), member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC25A4Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaTissue enhanced
SLC25A5Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC25A6Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC52A2Solute carrier family 52 (riboflavin transporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
SLC5A2Solute carrier family 5 (sodium/glucose cotransporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
SLC6A2Solute carrier family 6 (neurotransmitter transporter), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mitochondria
Cytosol		Tissue enhanced
SLC6A3Solute carrier family 6 (neurotransmitter transporter), member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesNot detected
SLC6A4Solute carrier family 6 (neurotransmitter transporter), member 4FDA approved drug targets
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles		Group enriched
SLC7A11Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
SLC8A1Solute carrier family 8 (sodium/calcium exchanger), member 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Plasma membrane		Tissue enhanced
SLCO2B1Solute carrier organic anion transporter family, member 2B1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SMOSmoothened, frizzled class receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Mixed
SMOXSpermine oxidaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Nuclear membrane
Vesicles		Tissue enhanced
SMSSpermine synthaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear bodies
Cytosol		Expressed in all
SNAP25Synaptosomal-associated protein, 25kDaDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SOAT1Sterol O-acyltransferase 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Endoplasmic reticulumTissue enhanced
SQLESqualene epoxidaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol		Mixed
SRCSRC proto-oncogene, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Mixed
SRD5A1Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Mixed
SSTR1Somatostatin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
SSTR2Somatostatin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolTissue enhanced
SSTR5Somatostatin receptor 5FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhanced

« prev | Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.